Amundi’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-24,217
Closed -$281K – 2191
2024
Q4
$281K Buy
24,217
+16,752
+224% +$202K ﹤0.01% 1673
2024
Q3
$81.9K Buy
7,465
+1,172
+19% +$13.7K ﹤0.01% 1792
2024
Q2
$78K Sell
6,293
-1,728
-22% -$26.4K ﹤0.01% 1739
2024
Q1
$112K Buy
8,021
+2,015
+34% +$31.8K ﹤0.01% 1746
2023
Q4
$93.9K Buy
6,006
+33
+0.6% +$459 ﹤0.01% 1787
2023
Q3
$68.5K Hold
5,973
– – ﹤0.01% 1822
2023
Q2
$85.1K Sell
5,973
-147
-2% -$2.15K ﹤0.01% 1806
2023
Q1
$91.9K Buy
+6,120
New +$99K ﹤0.01% 1760

Other funds holding OSG

Amundi's OSG Position: Q1 2025 in Review

Amundi sold out of Octave Specialty Group (OSG) in Q1 2025, closing a stake of 24,217 shares — an estimated $281K sold.

Amundi first reported a position in OSG in Q1 2023 and held it in 8 quarters. The position peaked at $281K in Q4 2024. 175 funds tracked by Wall St. Rank hold OSG as of Q1 2025.

  • Amundi reported no remaining Octave Specialty Group position as of Q1 2025 after selling out during the quarter.
  • Amundi sold 24,217 Octave Specialty Group shares in Q1 2025, an estimated $281K.
  • Amundi first reported a position in Octave Specialty Group in Q1 2023 and held it in 8 quarters.
  • Amundi's Octave Specialty Group position peaked at $281K in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2025.

Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.